...top GWAS signals included a novel SNP upstream of BP1FB2 (p = 0.0007, OR 27.6), an intronic variant SNP in ADAMTS3 (p = 0.0007, OR = 51.6), and an intronic variant in Wnt7a (p = 0.0009, OR 28.4) as associated with response to capecitabine treatment.